|
AEterna Zentaris Incorporated - Company Profile Snapshot
| Company Profile: |
AEterna Zentaris Incorporated |
| Ticker: |
AEZ |
| Exchanges: |
NAS MON TOR |
| 2008 Sales: |
40,898,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
CANADA |
| Employees: |
489 |
Business Description
AEterna Zentaris Incorporated. The Group's principal activity is to develop novel therapeutic treatments, mainly in cancer and endocrinology. The product pipeline includes products ranging from preclinical to marketing stage. Atrium develops and markets active ingredients and fine chemical products in the cosmetics, nutrition, fine chemical and pharmaceutical industries. The Group has operations in Canada, the United States, Europe, Switzerland, the United Kingdom, Netherlands and Japan.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
